ProfileGDS4095 / 202913_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 76% 74% 73% 73% 73% 73% 71% 72% 72% 73% 74% 72% 73% 72% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep17.9308976
GSM709769LY2 SRC1-siRNA tamoxifen treated rep37.5750174
GSM709765LY2 SRC1-siRNA untreated rep37.3815673
GSM709771LY2 SRC1-siRNA untreated rep17.4116273
GSM709772LY2 SRC1-siRNA untreated rep27.4618573
GSM709775LY2 SRC1-siRNA untreated rep47.4314173
GSM709764LY2 control-siRNA tamoxifen treated rep27.0733371
GSM709766LY2 control-siRNA tamoxifen treated rep37.2233872
GSM709768LY2 control-siRNA tamoxifen treated rep17.1520472
GSM709777LY2 control-siRNA tamoxifen treated rep47.3214173
GSM709770LY2 control-siRNA untreated rep37.5825974
GSM709773LY2 control-siRNA untreated rep17.3039772
GSM709774LY2 control-siRNA untreated rep27.4095473
GSM709776LY2 control-siRNA untreated rep47.2332572